A functional significance for codon third bases

Gene

Volumn 245, Issue 2, 2000, Pages 291-298

  Epstein, Richard J ^a,b   Lin, Kui ^c   Tan, Tin Wee ^c  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Molecular evolution

Indexed keywords

AMINO ACID; PROTEIN TYROSINE KINASE;

AMINO ACID SEQUENCE; ARTICLE; CELL FUNCTION; CELL SURVIVAL; CODON; CONTROLLED STUDY; GENE FUNCTION; GENE MUTATION; GENETIC TRANSCRIPTION; MITOGENESIS; MOLECULAR EVOLUTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

AMINO ACIDS; BASE COMPOSITION; BASE SEQUENCE; BINDING SITES; CODON; CYSTEINE; DATABASES, FACTUAL; GENES; HUMANS; MEMBRANE PROTEINS; MITOGENS; NUCLEOTIDES; POLYMORPHISM, GENETIC; RECEPTORS, CELL SURFACE; RECEPTORS, GROWTH FACTOR; SECOND MESSENGER SYSTEMS; TYROSINE;

EID: 0034696628     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(00)00042-1     Document Type: Article

References (29)

1. Asai N., Murakami H., Iwashatsi T., Takahashi M. A mutation at tyrosine 1062 in MEN2A-Ret and MEN2B-Ret impairs their transforming activity and association with Shc adaptor proteins. J. Biol. Chem. 271:1996;17644-17649.
2. Bilan P.J., Yip C.C. Unusual insulin binding to cells expressing an insulin receptor mutated at cysteine 524. Biochem. Biophys. Res. Commun. 205:1994;1891-1898.
3. Cooper D.N., Krawczak M. Cytosine methylation and the fate of CpG dinucleotides in vertebrate genomes. Hum. Genet. 83:1989;181-188.
4. Donis-Keller H., Dou S., Chi D. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum. Mol. Genet. 2:1993;851-856.
5. Epstein C.J. Non-randomness of amino-acid changes in the evolution of homologous proteins. Nature. 215:1967;355-359.
6. erbB3 possesses an impaired tyrosine kinase activity. Proc. Natl. Acad. Sci. USA. 91:1994;8132-8136.
7. Hansen K., Johnell M., Siegbahn A. Mutation of a Src phosphorylation site in the PDGF beta-receptor leads to increased PDGF-stimulated chemotaxis but decreased mitogenesis. EMBO J. 15:1996;5299-5313.
8. Hill T.D., Dean N.M., Mordan L.J., Lau A.F., Kenemitsu M.Y., Boynton A.L. PDGF-induced activation of phospholipase C is not required for induction of DNA synthesis. Science. 248:1990;1660-1662.
9. Hooshmand-Rad R., Yokote K., Heldin C.H., Claesson-Welsh L. PDGF alpha-receptor mediated cellular responses are not dependent on Src family kinases in endothelial cells. J. Cell Sci. 111:1998;607-614.
10. Inui H., Kitami Y., Tani M., Kondo T., Inagami T. Differences in signal transduction between PDGF alpha- and beta-receptors in vascular smooth muscle cells: PDGF-BB is a potent mitogen, but PDGF-AA promotes only protein synthesis without activation of DNA synthesis. J. Biol. Chem. 269:1994;30546-30552.
11. Kashishian A., Kazlauskas A., Cooper J.A. Phosphorylation sites in the PDGF receptor with different specificities for binding GAP and PI3 kinase in vivo. EMBO J. 11:1992;1373-1382.
12. Kitanaka A., Ito C., Nishigaki H., Campana D. CD38-mediated growth suppression of B-cell progenitors requires activation of phosphatidylinositol 3-kinase and involves its association with the protein product of the c-cbl proto-oncogene. Blood. 88:1996;590-598.
13. Kraus M.H., Issing W., Miki T., Popescu N.C., Aaronson S.A. Isolation and characterization of ERBB-3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors. Proc. Natl. Acad. Sci. USA. 86:1989;9193-9197.
14. 292 negative regulatory phosphorylation site of ZAP-70. J. Biol. Chem. 272:1997;33140-33144.
15. Miyazawa K., Backstrom G., Leppanen D. Role of immunoglobulin-like domains 2-4 of the platelet-derived growth factor α-receptor in ligand-receptor complex assembly. J. Biol. Chem. 273:1998;25495-25502.
16. Murphy M.A., Schnall R.G., Venter D.J., Barnett L., Bertoncello I., Thien C.B. Tissue hyperplasia and enhanced T cell signalling via ZAP-70 in c-Cbl-deficient mice. Mol. Cell. Biol. 18:1998;4872-4882.
17. Negre D., Cenatiempo Y., Cozzone A.J. High fidelity of guanine translation in a plasmid-directed in vitro system. Biochimie. 70:1988;1715-1718.
18. Nembrot M., Quintana B., Mordoh J. Estrogen receptor gene amplification is found in some estrogen receptor-positive human breast tumors. Biochem. Biophys. Res. Commun. 166:1990;601-607.
19. Ota Y., Samelson L.E. The product of the proto-oncogene c-cbl: a negative regulator of the Syk tyrosine kinase. Science. 276:1997;418-420.
20. Park J., Cartwright C.A. Src activity increases and Yes activity decreases during mitosis of human colon carcinoma cells. Mol. Cell. Biol. 15:1995;2374-2382.
21. Parker J., Johnston T.C., Borgia P.T., Holtz G., Remaut E., Fiers W. Codon usage and mistranslation. In vivo basal level misreading of the MS2 coat protein message. J. Biol. Chem. 258:1983;10007-10012.
22. Reese J.C., Katzenellenbogen B.S. Mutagenesis of cysteines in the hormone binding domain of the human estrogen receptor. J. Biol. Chem. 266:1991;10880-10887.
23. Rohrschneider L.R., Bourette R.P., Lioubin M.N. Growth and differentiation signals regulated by the M-CSF receptor. Mol. Reprod. Dev. 46:1997;96-103.
24. Ronco L.V., Doyle S.E., Raines S.M., Park L.S., Gasson J.C. Conserved amino acids in the human granulocyte-macrophage colony-stimulating factor receptor-binding subunit essential for tyrosine phosphorylation and proliferation. J. Immunol. 154:1995;3444-3453.
25. Semba K., Kamata N., Toyoshima K., Yamamoto T. A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1 epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma. Proc. Natl. Acad. Sci. USA. 82:1985;6497-6501.
26. Semba K., Nishizawa M., Satoh H. Nucleotide sequence and chromosomal mapping of the human c-yes-2 gene. Jpn. J. Cancer Res. 79:1988;710-717.
27. Siegel P.M., Dankort D.L., Hardy W.R., Muller W.J. Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors. Mol. Cell. Biol. 14:1994;7068-7077.
28. Sparrow L.G., McKern N.M., Gorman J.G. The disulfide bonds in the C-terminal domains of the insulin receptor ectodomain. J. Biol. Chem. 272:1997;29460-29467.
29. Stuber D., Friedlein A., Fountoulakis M., Lahm H.W., Garotta G. Alignment of disulfide bonds of the extracellular domain of the interferon gamma receptor and investigation of their role in biological activity. Biochemistry. 32:1993;2423-2430.